Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

https://phgkb.cdc.gov/GAPPKB/phgHome.do





Last Posted: May 25, 2017

---

• Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.  
  Nguyen Paul L et al. European urology 2017 May
• Use of the 4Kscore test to predict the risk of aggressive prostate cancer prior to prostate biopsy: Overall cost savings and improved quality of care to the us healthcare system.  
  Voigt Jeffrey D et al. Reviews in urology 2017 19(1) 1-10
• Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.  
  Conteduca V et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 May
• Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that  
  S Begley, StatNews, May 4, 2017
• Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study —Π 
  V. Conteduca, et al. Ann Oncology, May 2017
• Decision making tools in prostate cancer: from risk grouping to nomograms.  
  Fontanella Paolo et al. Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2017 Mar
• Prognostic outlier genes for enhanced prostate cancer treatment.  
  Kim Hyun et al. Future oncology (London, England) 2017 Feb 13(3) 249-261
• Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.  
  Alvarez-Cubero M J et al. Molecular diagnosis & therapy 2017 Apr 21(2) 167-178
• The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.  
  Cremers Ruben G et al. The Prostate 2016 76(10) 897-904
• The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.  
  Bibbins-Domingo Kirsten et al. JAMA 2017 Apr
• The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.  
  Barbieri Christopher E et al. European urology 2017 Feb (2) 237-246
• The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer An Invitation to Review and Comment  
  USPSTF, JAMA April 11, 2017
• Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.  
  Spratt Daniel E et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar JCO2016702811
• A comparison of genetic risk score with family history for estimating prostate cancer risk.  
  Helfand Brian T et al. Asian journal of andrology 18(4) 515-9
• Genomic tests to guide prostate cancer management following diagnosis.  
  Colicchia Michele et al. Expert review of molecular diagnostics 2017 Mar 1-11
• Characterisation of microbial communities within aggressive prostate cancer tissues.  
  Yow Melissa A et al. Infectious agents and cancer 2017 4

more